CRYO-CELL INTERNATIONAL, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CRYO-CELL INTERNATIONAL, INC. payments for repurchase of common stock for the quarter ending 2025-11-30 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. payments for repurchase of common stock for the quarter ending 2025-08-31 was $80.88K, a 393.19% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. payments for repurchase of common stock for the quarter ending 2025-05-31 was $88.62K, a 92.84% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. payments for repurchase of common stock for the quarter ending 2025-02-28 was $0.00, a 100.00% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. payments for repurchase of common stock for fiscal 2025 was $169.50K, a 88.10% decline from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. payments for repurchase of common stock for fiscal 2024 was $1.42M, a 78.20% increase from fiscal 2023.
- CRYO-CELL INTERNATIONAL, INC. payments for repurchase of common stock for fiscal 2023 was $799.04K, a 56.09% decline from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. payments for repurchase of common stock for fiscal 2022 was $1.82M, a 629.78% increase from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $169.50K 10-K · filed 2026-02-27 |
| 2025-08-31 | $80.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | $169.50K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-05-31 | $88.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $105.02K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-02-28 | $0.00 10-Q · filed 2025-04-14 | $1.25M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.42M 10-K · filed 2026-02-27 |
| 2024-08-31 | $16.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | $1.42M derived: sum of 4 quarters · filed 2025-10-15 |
| 2024-05-31 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-15 | $1.42M derived: sum of 4 quarters · filed 2025-07-15 |
| 2024-02-29 | $170.38K 10-Q · filed 2025-04-14 | $726.21K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $799.04K 10-K · filed 2025-02-28 |
| 2023-08-31 | $7.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-15 | $926.52K derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | $548.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-15 | $1.19M derived: sum of 4 quarters · filed 2024-07-15 |
| 2023-02-28 | $243.20K 10-Q · filed 2024-04-15 | $1.23M derived: sum of 4 quarters · filed 2024-04-15 |
| 2022-11-30 | $127.48K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.82M 10-K · filed 2024-02-28 |
| 2022-08-31 | $266.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-12 | $1.94M derived: sum of 4 quarters · filed 2023-10-12 |
| 2022-05-31 | $596.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-14 | $1.67M derived: sum of 4 quarters · filed 2023-07-14 |
| 2022-02-28 | $828.98K 10-Q · filed 2023-04-21 | |
| 2021-11-30 | $249.38K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $249.38K 10-K · filed 2023-02-28 |
| 2021-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-18 | |
| 2019-11-30 | $992.24K 10-K · filed 2021-03-01 | |
| 2017-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $446.62K 10-K · filed 2019-02-28 |
| 2017-08-31 | $42.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-15 | $584.68K derived: sum of 4 quarters · filed 2018-10-15 |
| 2017-05-31 | $315.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-16 | $10.77M derived: sum of 4 quarters · filed 2018-07-16 |
| 2017-02-28 | $88.69K 10-Q · filed 2018-04-16 | $10.49M derived: sum of 4 quarters · filed 2018-04-16 |
| 2016-11-30 | $138.06K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $10.81M 10-K · filed 2018-02-28 |
| 2016-08-31 | $10.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-16 | $10.93M derived: sum of 4 quarters · filed 2017-10-16 |
| 2016-05-31 | $34.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-11 | $2.70M derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-02-29 | $408.40K 10-Q · filed 2017-04-13 | $3.57M derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-11-30 | $258.73K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.21M 10-K · filed 2017-02-28 |
| 2015-08-31 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | $3.32M derived: sum of 4 quarters · filed 2016-10-17 |
| 2015-05-31 | $913.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-11 | $2.22M derived: sum of 4 quarters · filed 2016-07-11 |
| 2015-02-28 | $39.04K 10-Q · filed 2016-04-14 | $2.26M derived: sum of 4 quarters · filed 2016-04-14 |
| 2014-11-30 | $376.43K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.67M 10-K · filed 2016-02-29 |
| 2014-08-31 | $887.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-15 | $2.36M derived: sum of 4 quarters · filed 2015-10-15 |
| 2014-05-31 | $955.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-15 | $1.48M derived: sum of 4 quarters · filed 2015-07-15 |
| 2014-02-28 | $451.91K 10-Q · filed 2015-04-14 | $943.49K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-11-30 | $66.55K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $738.62K 10-K · filed 2015-03-02 |
| 2013-08-31 | $4.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-15 | $904.31K derived: sum of 4 quarters · filed 2014-10-15 |
| 2013-05-31 | $420.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-03 | $970.47K derived: sum of 4 quarters · filed 2014-07-03 |
| 2013-02-28 | $247.04K 10-Q · filed 2014-04-14 | $1.20M derived: sum of 4 quarters · filed 2014-04-14 |
| 2012-11-30 | $232.24K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.70M 10-K · filed 2014-02-28 |
| 2012-08-31 | $70.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-15 | |
| 2012-05-31 | $646.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-15 | |
| 2012-02-29 | $753.51K 10-Q · filed 2013-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |